Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4752 |  LGVN Longeveron Inc. - Class A Common stock | 2.37 USD | -2.87% | -7.42% | -64.15% | +315.79% | 7.56 M USD | ||
| 4755 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.76 USD | -1.04% | +1.28% | -9.51% | +570.42% | 7.46 M USD | ||
| 4756 |  SKYE Skye Bioscience, Inc. - Common Stock | 1.68 USD | +1.82% | +2.44% | -10.64% | +110.00% | 7.44 M USD | ||
| 4759 |  FBLG FibroBiologics, Inc. - Common Stock | 1.11 USD | -2.63% | -7.50% | -35.84% | +126.53% | 7.39 M USD | ||
| 4760 |  TRAW Traws Pharma, Inc. - Common Stock | 0.48 USD | 0.00% | -14.29% | -12.73% | -81.03% | 7.38 M USD | ||
| 4765 |  INM InMed Pharmaceuticals Inc. - Common Shares | 1.33 USD | 0.00% | -2.92% | +1.53% | -43.40% | 7.31 M USD | ||
| 4766 |  APRE Aprea Therapeutics, Inc. - Common Stock | 0.56 USD | -8.20% | -22.22% | -28.21% | -62.67% | 7.05 M USD | ||
| 4767 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.63 USD | +0.83% | +3.71% | -2.16% | -38.99% | 6.99 M USD | ||
| 4771 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.52 USD | +1.33% | +0.66% | +2.70% | -38.21% | 6.80 M USD | ||
| 4779 |  XCUR Exicure, Inc. - Common Stock | 1.01 USD | -0.98% | -13.68% | -28.37% | -82.59% | 6.61 M USD | ||
| 4780 |  ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.25 USD | -3.85% | -2.34% | -11.35% | -34.90% | 6.59 M USD | ||
| 4782 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.34 USD | -2.19% | -0.74% | -19.76% | -41.99% | 6.47 M USD | ||
| 4794 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.74 USD | -2.09% | -5.79% | +884.21% | +199.20% | 6.09 M USD | ||
| 4796 |  IMNN Imunon, Inc. - Common Stock | 1.07 USD | -4.46% | -20.74% | -30.52% | -67.08% | 6.00 M USD | ||
| 4803 |  KALA KALA BIO, Inc. - Common Stock | 0.30 USD | -16.67% | -26.83% | -46.43% | -80.52% | 5.80 M USD | ||
| 4808 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.86 USD | -2.27% | -6.52% | -18.10% | -75.29% | 5.67 M USD | ||
| 4812 |  PULM Pulmatrix, Inc. - Common Stock | 1.53 USD | +2.68% | -3.77% | +1.32% | -67.52% | 5.59 M USD | ||
| 4815 |  LEXX Lexaria Bioscience Corp. - Common Stock | 3.36 USD | -4.00% | +5.66% | -52.00% | +286.21% | 5.55 M USD | ||
| 4818 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.86 USD | -5.58% | -5.58% | -6.06% | -29.01% | 5.50 M USD | ||
| 4820 |  AIM AIM ImmunoTech Inc. Common Stock | 0.18 USD | 0.00% | -5.26% | -21.74% | -93.10% | 5.48 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |